STU:ELN (Germany)
Â
Akt. nach Kapitalherabsetzung
€
0.05
(0%)
Jan 26
Business Description
Elanix Biotechnologies AG
SIC : 5990
ISIN : DE000A0WMJQ4
Share Class Description:
STU:ELN: Akt. nach KapitalherabsetzungCompare
Compare
Traded in other countries / regions
ELN.Germany0NQA.UK Description
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 46.88 | |||||
| 12-1 Month Momentum % | -44.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3695.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elanix Biotechnologies AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.062 | ||
| EPS (TTM) (€) | -12.49 | ||
| Beta | 0 | ||
| Volatility % | 50.28 | ||
| 14-Day RSI | 46.88 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.05 | ||
| 12-1 Month Momentum % | -44.44 | ||
| 52-Week Range (€) | 0.04 - 0.15 | ||
| Shares Outstanding (Mil) | 8.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Elanix Biotechnologies AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Elanix Biotechnologies AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Elanix Biotechnologies AG Frequently Asked Questions
What is Elanix Biotechnologies AG(STU:ELN)'s stock price today?
The current price of STU:ELN is €0.05. The 52 week high of STU:ELN is €0.15 and 52 week low is €0.04.
When is next earnings date of Elanix Biotechnologies AG(STU:ELN)?
The next earnings date of Elanix Biotechnologies AG(STU:ELN) is .
Does Elanix Biotechnologies AG(STU:ELN) pay dividends? If so, how much?
Elanix Biotechnologies AG(STU:ELN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers